Halozyme Therapeutics shares owned by Edgestream Partners
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Edgestream Partners
from 13F filings
Historical chart of Edgestream Partners investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Edgestream Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Edgestream Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $776k | 16k | 47.81 |
| 2024-09-30 | $4.9M | 86k | 57.24 |
| 2024-06-30 | $2.1M | 40k | 52.36 |
| 2024-03-31 | $2.7M | 65k | 40.68 |
| 2023-12-31 | $531k | 14k | 36.96 |
| 2023-09-30 | $396k | 10k | 38.20 |
| 2023-06-30 | $859k | 24k | 36.07 |
| 2023-03-31 | $1.9M | 49k | 38.19 |
| 2022-12-31 | $1.8M | 31k | 56.90 |
| 2022-09-30 | $2.2M | 56k | 39.55 |